A Framework to Guide the Optimal Development and Use of Real World Evidence for Coverage and Formulary Decisions
These papers evaluates potential opportunities, challenges, and limitations that must be addressed in considering options for using RWE to inform insurer coverage decisions. Date of review: December 2017 For more information, please contact info@icer.org Final Documents Below you will find the final documents from the policy paper review process:
Recent Comments